Jessica Song, MA, Pharm.D.
Jessica Song, M.A., Pharm.D. is the Santa Clara Valley Health & Hospital Systems (SCVH&HS) Pharmacy Residency Coordinator (since 2004) and was a faculty member of the University of the Pacific School of Pharmacy from 2001 to 2010 (tenured, 2007).
She received a Master of Arts degree in Physical Chemistry at the Johns Hopkins University in 1993 and graduated from the University of California, San Francisco School of Pharmacy in 1998. She spent three years at Hartford Hospital where she received training as a pharmacy resident and as a fellow of cardiovascular pharmacotherapy.
She is a co-author of three book chapters for the Applied Therapeutics textbook that is used by more than seventy schools of pharmacy throughout the United States.
She was a co-recipient of the American Association of Hospital Pharmacists' Research and Education Foundation Award for Drug Therapy Research in 2004 and has won numerous teaching awards over the past decade.
She is currently serving as the Clinical Supervisor of Ambulatory Care/Pharmacy &Therapeutics at Santa Clara Valley Medical Center. She oversees the operation of multiple clinics, including the Refill Authorization Center, the Medical Home Model/Diabetes Clinic, the Renal Center, and the Anticoagulation Clinic. She supervises coordinators of the Pharmacy and Therapeutics Committee and multiple subcommittees, including Anti-Infective Evaluation, Formulary Management, Medication Safety, and Medication Utilization Management. Starting in June 2011, she will start managing clinical pharmacy operations in the Division of Mental Health at SCVH&HS.
She has been an active member of the California Society of Health-System Pharmacists since 2001. She served as the President-Elect in 2002 for the Central Valley Chapter and is currently serving as a delegate for the South Bay Chapter.
Research Interests
Jessica Song has conducted research in the areas of cardiology and infectious disease since graduating from the Hartford Hospital Cardiovascular Pharmacotherapy Fellowship program. She studied the QT-prolonging effects of intravenous moxifloxacin in medical ward patients at SCVH&HS and has also researched the impact of obesity on the dosing of vancomycin. In recent years, she has focused her attention on the pharmacokinetics/pharmacogenomics of efavirenz in Hispanic and Vietnamese patients.
